Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01015
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2019
Authors
Publisher
Frontiers Media SA